(Q42483046)

1 November 2017

title

Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression (English)

1 reference

1 November 2017

1 reference

1 reference

Erika Abel

5

0 references

author name string

Inok Surh

1

1 reference

1 November 2017

Joyce Rundhaug

2

1 reference

1 November 2017

Amy Pavone

3

1 reference

1 November 2017

Carol Mikulec

4

1 reference

1 November 2017

Susan M Fischer

6

1 reference

1 November 2017

publication date

25 January 2011

1 reference

1 November 2017

published in

Molecular Carcinogenesis

1 reference

1 November 2017

volume

50

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

458-468

1 reference

Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

1 November 2017

cites work

1 reference

The role of COX-2 in oral cancer development, and chemoprevention/ treatment of oral cancer by selective COX-2 inhibitors

21 January 2018

1 reference

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

21 January 2018

1 reference

Immunohistochemical expression of cyclooxygenase-2 in skin cancers

21 January 2018

1 reference

Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2.

21 January 2018

1 reference

Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition

21 January 2018

1 reference

Enhancement of colon carcinogenesis by prostaglandin E2 administration

21 January 2018

1 reference

Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis

21 January 2018

1 reference

The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.

21 January 2018

1 reference

Reactive oxygen in the tumor promotion stage of skin carcinogenesis.

21 January 2018

1 reference

Cyclooxygenase-2 and its role in colorectal cancer development

21 January 2018

1 reference

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

21 January 2018

1 reference

Immunolocalization of low-affinity prostaglandin E receptors, EP and EP, in adult human epidermis

21 January 2018

1 reference

Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer

21 January 2018

1 reference

The expression pattern of prostaglandin E synthase and EP receptor isoforms in normal mouse skin and preinvasive skin neoplasms

21 January 2018

1 reference

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

21 January 2018

1 reference

Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.

21 January 2018

1 reference

Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development

21 January 2018

1 reference

Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development

21 January 2018

1 reference

Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.

21 January 2018

1 reference

A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.

21 January 2018

1 reference

Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development

21 January 2018

1 reference

Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.

21 January 2018

1 reference

The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1

21 January 2018

1 reference

Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.

21 January 2018

1 reference

Prostaglandin E(2) (PGE(2)) induces the c-fos and c-jun expressions via the EP(1) subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

21 January 2018

1 reference

Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis

21 January 2018

1 reference

Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium

21 January 2018

1 reference

Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer

21 January 2018

1 reference

Prostaglandin E2 (PGE2) autoamplifies its production through EP1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

21 January 2018

1 reference

Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.20730

1 reference

1 November 2017

1 reference